Skip to content
Rglax Pharma

Export region

Tablet coating material exported to Australia and New Zealand

TGA and Medsafe oversight, with a large complementary medicines sector alongside pharmaceutical manufacture.

What this region runs

Australia carries a substantial complementary medicines and supplements manufacturing sector alongside conventional pharmaceutical production, much of it producing coated tablets in volume. TGA requirements for listed and registered goods differ, and that affects what an excipient supplier has to provide.

Why our range fits it

The nutraceutical and complementary medicines side of our range is directly relevant here, and it is a segment we already supply at scale in India. Conventional pharmaceutical work runs to European and British Pharmacopoeia expectations.

What to send us

Say whether the product is a listed complementary medicine or a registered pharmaceutical, because the documentation path is not the same.

Market facts

Markets
Australia, New Zealand
Pharmacopoeia
British Pharmacopoeia and European Pharmacopoeia, with USP accepted.
Exported from
Plot No. 30, Industrial Area Tahliwal, Himachal Pradesh, India
Compliance
WHO-GMP Compliance Unit

Regulators you would be working under

  • TGA, Australia
  • Medsafe, New Zealand

Listed so you know the framework we would be supplying into. It is not a claim that we hold a registration or approval with any of them.

What ships to Australia and New Zealand

Tablets coated on our own pan at Tahliwal. Shade is matched against a retained sample you send us, not against a colour code.

  • Metallic blue coated tablets beside an Rglax DB3012 coating dispersion

    Metallic blue DB3012

  • Orange film coated caplets with a break line

    Aqueous colour film coat

  • White film coated round tablets

    Extra white film coat

  • Metallic blue round coated tablets

    Pearl and metallic finish

Call usWhatsApp